Taking Colchicine to Treat Gout

Taking Colchicine to Treat Gout

Indications, Dosages, and Common Side Effects

By Carol Eustice
Updated on August 03, 2024
Medically reviewed by Stella Bard, MD

Table of Contents
View All
Table of Contents

Colchicine is a cornerstone medication for managing gouty arthritis, a painful inflammatory condition affecting the joints. Available both as the brand-name medication Colcrys and in generic form, colchicine is derived from the dried seeds of Colchicum autumnale, commonly known as the autumn crocus or meadow saffron. Its long history of use and proven efficacy make it a preferred therapeutic option, particularly for addressing acute gout attacks and for ongoing preventive treatment. Understanding how to use this medication effectively is crucial for individuals seeking to manage their gout symptoms and improve their quality of life.

Foot pain from gout.
Jan-Otto/E+/Getty Images

Indications for Using Colchicine

The therapeutic application of alkaloids derived from Colchicum autumnale for treating gout is far from new; its use can be traced back to 1810, and its medicinal value was recognized as early as the first century A.D. This deep historical root underscores colchicine’s enduring role in gout management. It is primarily prescribed to manage the acute flares of gout, characterized by sudden, severe joint pain, swelling, and redness, as well as to prevent future attacks in individuals susceptible to this condition.

Beyond its primary indication for gout, colchicine demonstrates versatility in treating a range of other inflammatory conditions. Its anti-inflammatory properties lend themselves to managing disorders that involve systemic inflammation. While not a first-line treatment for all these conditions, it plays a supportive or primary role in specific cases. These additional indications highlight the broad spectrum of therapeutic applications for this historically significant medication, showcasing its unique pharmacological profile.

Specifically, colchicine can be used to manage conditions beyond gout, including:

  • Amyloidosis2
  • Behcet's disease3
  • Dermatitis herpetiformis4
  • Familial Mediterranean fever5
  • Paget's disease6
  • Pericarditis7
  • Pseudogout8

Mechanism of Action

Colchicine is well-regarded for its potent anti-inflammatory effects. However, it's important to understand that its utility in managing pain extends almost exclusively to conditions like gout, where inflammation is driven by specific cellular mechanisms. Unlike conventional analgesics, colchicine does not directly relieve pain in a general sense, nor does it influence the underlying high uric acid levels that are characteristic of gout. Its effectiveness stems from a highly targeted action on the body's inflammatory response rather than simply masking pain or addressing the root cause of uric acid accumulation.

The mechanism by which colchicine acts is distinct and highly specific. It works by forming a complex with tubulin, a protein critical for the structure and function of various cell components, particularly in white blood cells known as neutrophils. By binding to these neutrophils, colchicine effectively impairs their ability to migrate to sites where uric acid crystals have accumulated within the joints. This inhibition of neutrophil movement directly tempers the acute inflammatory response that characterizes a gout flare, thereby significantly reducing the associated pain and discomfort. Furthermore, this suppressive effect helps decrease the frequency and severity of future acute gout attacks, providing crucial relief for patients.9

Dosages

Colchicine therapy is typically initiated for individuals experiencing two or more gout attacks per year, signaling a need for proactive management. The standard starting dose for these patients involves taking two 0.6 mg colchicine tablets daily. This regimen is usually maintained concurrently with uric acid-lowering therapies, such as Uloric or allopurinol, which aim to reduce the overall uric acid levels in the body. The combination therapy continues until the patient's uric acid level consistently falls below 6.0 mg/dL, indicating successful control of the underlying metabolic issue contributing to gout. This integrated approach ensures both immediate relief from inflammation and long-term disease management.

During acute gout flares, the dosage of colchicine may be temporarily increased to three tablets daily for a few days to rapidly bring the inflammation under control. However, it is crucial to monitor for gastrointestinal discomfort or diarrhea, which are common side effects at higher doses. Should these symptoms arise, the daily dose may need to be decreased to one tablet daily, or the medication may need to be stopped entirely to alleviate discomfort and prevent further complications. Patient comfort and tolerability are paramount, and adjustments should always be made under medical guidance to ensure the treatment is effective and manageable.

Colchicine also serves a vital role in the prophylactic, or preventive, management of gout, recommended for regular use between acute attacks. For individuals who experience less than one gout attack annually, a typical preventive dose is 0.5 or 0.6 mg per day, administered three or four days a week. For those who face more frequent episodes, exceeding one attack per year, the usual prophylactic dose is 0.5 or 0.6 mg daily. In more severe or persistent cases, healthcare providers might prescribe two or three 0.5 mg or 0.6 mg tablets daily to achieve adequate prevention. These dosages are tailored to the individual's attack frequency and severity, aiming to reduce the likelihood of future painful flares.9

It is important to note that while colchicine is widely used in adults for acute gout flares, its prophylactic use in adolescents is typically reserved for those aged 16 and over. For pediatric patients, colchicine has a very specific and limited approved indication. Its only approved use in children is for the treatment of Familial Mediterranean Fever (FMF), a genetic inflammatory disorder. This strict age and condition-specific guideline underscores the careful consideration and specialized medical oversight required when prescribing colchicine, particularly for younger patients, ensuring its use is both appropriate and safe for their specific health needs.

Side Effects

When taking colchicine, it is important to be aware of the potential for adverse reactions, which can range from mild to severe. A significant concern, particularly with long-term therapy, is bone marrow depression. This serious condition can manifest as aplastic anemia (a deficiency of all types of blood cells), agranulocytosis (a severe lack of white blood cells, increasing infection risk), or thrombocytopenia (low platelet count, affecting blood clotting). Regular monitoring by a healthcare professional is essential for patients on prolonged colchicine regimens to detect and manage these potential hematologic complications promptly, ensuring patient safety throughout the treatment course.10

In addition to bone marrow suppression, other possible adverse reactions associated with colchicine use warrant attention. These include peripheral neuritis, which involves nerve damage leading to pain, numbness, or weakness, and purpura, characterized by purple spots on the skin due to bleeding under the surface. Patients may also experience myopathy, a condition causing muscle weakness and pain, or hair loss. Furthermore, reversible azoospermia, a complete absence of sperm in semen, has been reported. While often reversible upon discontinuation of the drug, these side effects highlight the importance of open communication with your doctor about any new or worsening symptoms during treatment.11, 12

More commonly, patients undergoing colchicine therapy may experience gastrointestinal side effects such as vomiting, diarrhea, and nausea. These symptoms are particularly prevalent when the maximum prescribed doses are administered, indicating a dose-dependent relationship. To help mitigate these uncomfortable digestive issues, it is often recommended that colchicine be taken with food. This simple adjustment can significantly reduce the likelihood and severity of gastrointestinal distress, making the medication more tolerable and improving adherence to the prescribed treatment plan. Always consult with your healthcare provider for personalized advice on managing side effects.10

Considerations and Contraindications for Taking Colchicine

For pregnant women, the decision to use colchicine requires a careful assessment of the potential benefits weighed against the inherent risks. Colchicine has the capacity to arrest cell division, which poses a significant theoretical risk to a developing fetus. Therefore, it should only be considered during pregnancy if the potential therapeutic benefits for the mother undeniably justify the potential risks to the fetus. Similarly, caution is advised when colchicine is administered to women who are nursing, as the drug can pass into breast milk. Healthcare providers will thoroughly discuss these implications to ensure the safest possible approach for both mother and child.13

Beyond pregnancy, several critical considerations and absolute contraindications govern the use of colchicine to ensure patient safety and optimize treatment outcomes. Individuals with a known hypersensitivity or allergic reaction to colchicine should strictly avoid its use. Furthermore, the medication is contraindicated in anyone suffering from a serious gastrointestinal, renal (kidney), hepatic (liver), or cardiac (heart) disorder. These conditions can significantly impair the body's ability to process and eliminate the drug, leading to potentially dangerous accumulations and exacerbated side effects. Therefore, a comprehensive medical history is essential before initiating colchicine therapy.10

Moreover, individuals diagnosed with pre-existing blood disorders should not use colchicine due to the drug’s potential to cause or worsen bone marrow depression, a severe adverse effect. This includes conditions like aplastic anemia, agranulocytosis, or thrombocytopenia. The presence of any blood-related abnormality necessitates a thorough evaluation by a healthcare professional to determine if colchicine is a safe and appropriate treatment option. Always ensure your doctor is aware of all your medical conditions and current medications to prevent adverse interactions and ensure the safest and most effective management of your gout.

Gout Doctor Discussion Guide

Get our printable guide for your next doctor's appointment to help you ask the right questions.
Download PDF

Sign up for our Health Tip of the Day newsletter, and receive daily tips that will help you live your healthiest life.
Email Address
Sign Up
You're in!
Thank you, , for signing up.
There was an error. Please try again.

Read more:

13 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

  1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. Colchicine.
  2. Unverdi S, Inal S, Ceri M, et al. Is colchicine therapy effective in all patients with secondary amyloidosis?. Ren Fail. 2013;35(8):1071-4. doi:10.3109/0886022X.2013.811345
  3. Nair JR, Moots RJ. Behcet's disease. Clin Med (Lond). 2017;17(1):71-77. doi:10.7861/clinmedicine.17-1-71
  4. Silvers DN, Juhlin EA, Berczeller PH, Mcsorley J. Treatment of dermatitis herpetiformis with colchicine. Arch Dermatol.
  5. Sönmez HE, Batu ED, Özen S. Familial Mediterranean fever: current perspectives. J Inflamm Res. 2016;9:13-20. doi:10.2147/JIR.S91352
  6. Theodors A, Askari AD, Wieland RG. Colchicine in the treatment of Paget disease of bone: a new therapeutic approach. Clin Ther.
  7. Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A. Colchicine for pericarditis. Cochrane Database Syst Rev. 2014;(8):CD010652. doi:10.1002/14651858.CD010652.pub2.
  8. Macmullan P, Mccarthy G. Treatment and management of pseudogout: insights for the clinician. Ther Adv Musculoskelet Dis. 2012;4(2):121-31. doi:10.1177/1759720X11432559
  9. Engel B, Just J, Bleckwenn M, Weckbecker K. Treatment Options for Gout. Dtsch Arztebl Int. 2017;114(13):215-222. doi:10.3238/arztebl.2017.0215
  10. Sadiq NM, Robinson KJ, Terrell JM. Colchicine. In: StatPearls. Treasure Island (FL): StatPearls Publishing.
  11. Altiparmak MR, Pamuk ON, Pamuk GE, Hamuryudan V, Ataman R, Serdengecti K. Colchicine neuromyopathy: a report of six cases. Clin Exp Rheumatol.
  12. Ding J, Shang X, Zhang Z, et al. FDA-approved medications that impair human spermatogenesis. Oncotarget. 2017;8(6):10714-10725. doi:10.18632/oncotarget.12956
  13. Indraratna PL, Virk S, Gurram D, Day RO. Use of colchicine in pregnancy: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(2):382-387. doi:10.1093/rheumatology/kex353

Additional Reading

By Carol Eustice Carol Eustice is a writer covering arthritis and chronic illness, who herself has been diagnosed with both rheumatoid arthritis and osteoarthritis.
See Our Editorial Process
Meet Our Medical Expert Board